Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies.
Poullennec KG, Jnoff E, Abendroth J, Bhuma N, Calmiano M, Calmus L, Cardenas A, Courade JP, Delatour C, Hall A, de Haro T, Delker SL, Demaude T, Gaikwad N, Ghavate D, Gholap AR, Kierkowicz M, Le Mestre R, Van Hijfte N, Verheijden S, Vernerova K, De Wever V, Waghmode N. Poullennec KG, et al. Among authors: le mestre r. J Med Chem. 2024 Dec 12;67(23):20879-20910. doi: 10.1021/acs.jmedchem.4c01237. Epub 2024 Nov 26. J Med Chem. 2024. PMID: 39588908
Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.
Patrikidou A, Saieva C, Lee-Ying R, Nuzzo PV, Zarif TE, McClure H, Davidsohn M, Eid M, Spinelli GP, Catalano F, Cremante M, Fotia G, Rossetti S, Valenca L, Vauchier C, Ottanelli C, Andrade L, Gennusa V, Mestre RP, Fornarini G, Pignata S, Procopio G, Santini D, Ravi P, Sweeney C, Heng D, De Giorgi U, Fizazi K, Russo A, Francini E; SPARTACUSS Group. Patrikidou A, et al. Among authors: mestre rp. Clin Genitourin Cancer. 2024 Dec;22(6):102230. doi: 10.1016/j.clgc.2024.102230. Epub 2024 Oct 5. Clin Genitourin Cancer. 2024. PMID: 39461026 Free article.
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study.
Fotia G, Saieva C, Lee-Ying R, Patrikidou A, Nuzzo PV, Zanardi E, Rossetti S, Davidsohn M, Eid M, El Zarif T, McClure H, Spinelli GP, Damassi A, Murianni V, Vauchier C, Oliveira TM, Malgeri A, Modesti M, Mestre RP, Valenca L, Ravi P, Santini D, Pignata S, De Giorgi U, Sweeney C, Heng D, Procopio G, Russo A, Francini E; Spartacuss Group. Fotia G, et al. Among authors: mestre rp. Clin Genitourin Cancer. 2024 Oct;22(5):102185. doi: 10.1016/j.clgc.2024.102185. Epub 2024 Aug 9. Clin Genitourin Cancer. 2024. PMID: 39217072 Free article.
Ethics and responsibility in biohybrid robotics research.
Mestre R, Astobiza AM, Webster-Wood VA, Ryan M, Saif MTA. Mestre R, et al. Proc Natl Acad Sci U S A. 2024 Jul 30;121(31):e2310458121. doi: 10.1073/pnas.2310458121. Epub 2024 Jul 23. Proc Natl Acad Sci U S A. 2024. PMID: 39042690 Free PMC article.
Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis.
Garreta E, Moya-Rull D, Marco A, Amato G, Ullate-Agote A, Tarantino C, Gallo M, Esporrín-Ubieto D, Centeno A, Vilas-Zornoza A, Mestre R, Kalil M, Gorroñogoitia I, Zaldua AM, Sanchez S, Izquierdo Reyes L, Fernández-Santos ME, Prosper F, Montserrat N. Garreta E, et al. Among authors: mestre r. Adv Mater. 2024 Aug;36(34):e2400306. doi: 10.1002/adma.202400306. Epub 2024 Jun 12. Adv Mater. 2024. PMID: 38762768 Free article.
Synthetic DNA-based Swimmers Driven by Enzyme Catalysis.
Patiño Padial T, Del Grosso E, Gentile S, Baranda Pellejero L, Mestre R, Paffen LJMM, Sánchez S, Ricci F. Patiño Padial T, et al. Among authors: mestre r. J Am Chem Soc. 2024 May 8;146(18):12664-12671. doi: 10.1021/jacs.4c02094. Epub 2024 Apr 8. J Am Chem Soc. 2024. PMID: 38587543
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Nuzzo PV, Pederzoli F, Saieva C, Zanardi E, Fotia G, Malgeri A, Rossetti S, Valenca Bueno L, Andrade LMQS, Patrikidou A, Mestre RP, Modesti M, Pignata S, Procopio G, Fornarini G, De Giorgi U, Russo A, Francini E; SPARTACUSS Investigators. Nuzzo PV, et al. Among authors: mestre rp. J Transl Med. 2023 Feb 3;21(1):75. doi: 10.1186/s12967-022-03861-2. J Transl Med. 2023. PMID: 36737752 Free PMC article.
40 results